1,492
Views
83
CrossRef citations to date
0
Altmetric
Reviews

Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders

, MD PhD (University Professor) & , PhD
Pages 71-79 | Published online: 07 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sophie Dorsey & Fayyaz Ahmed. (2021) Developments in distinguishing secondary vascular headache from primary headache disorders in clinical practice. Expert Review of Neurotherapeutics 21:12, pages 1357-1369.
Read now
Josef Finsterer. (2019) Pharmacotherapeutic management of epilepsy in MERRF syndrome. Expert Opinion on Pharmacotherapy 20:10, pages 1289-1297.
Read now
Gabriel C Quintero. (2017) Review about gabapentin misuse, interactions, contraindications and side effects. Journal of Experimental Pharmacology 9, pages 13-21.
Read now
Josef Finsterer & Sinda Zarrouk-Mahjoub. (2016) Managing seizures in mitochondrial disorders. Expert Opinion on Orphan Drugs 4:2, pages 197-204.
Read now

Articles from other publishers (79)

Simon Maier, Kathrin Nickel, Thomas Lange, Georg Oeltzschner, Michael Dacko, Dominique Endres, Kimon Runge, Anke Schumann, Katharina Domschke, Michalis Rousos & Ludger Tebartz van Elst. (2023) Increased cerebral lactate levels in adults with autism spectrum disorders compared to non-autistic controls: a magnetic resonance spectroscopy study. Molecular Autism 14:1.
Crossref
Mingmin Zhao, Chun Zuo, Hongyu Hao, Xing Xing, Lei Zhao & Na Li. (2023) A patient with MELAS syndrome combined with autoimmune abnormalities: a case report. Frontiers in Neurology 14.
Crossref
Jing Wang, LIjuan Huang, Hua Li, Guohong Chen, Liming Yang, Dong Wang, Hong Han, Guo Zheng, Xu Wang, Jianmin Liang, Weijie He, Fang Fang, Jianxiang Liao & Dan Sun. (2023) Effects of ketogenic diet on the classification and functional composition of intestinal flora in children with mitochondrial epilepsy. Frontiers in Neurology 14.
Crossref
Adriana Celdran de Castro, Fábio A. Nascimento, Álvaro Beltran-Corbellini, Rafael Toledano, Irene Garcia-Morales, Antonio Gil-Nagel & Ángel Aledo-Serrano. (2023) Levetiracetam, from broad-spectrum use to precision prescription: A narrative review and expert opinion. Seizure: European Journal of Epilepsy 107, pages 121-131.
Crossref
Jennifer M Argudo, Olga M Astudillo Moncayo, Walter Insuasti, Gabriela Garofalo, Alex S Aguirre, Sebastian Encalada, Jose Villamarin, Sebastian Oña, Maria Gabriela Tenemaza, Ahmed Eissa-Garcés, Sakina Matcheswalla & Juan Fernando Ortiz. (2022) Arginine for the Treatment of Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes: A Systematic Review. Cureus.
Crossref
Natalia Będkowska, Aneta Zontek & Justyna Paprocka. (2022) Stroke-like Episodes in Inherited Neurometabolic Disorders. Metabolites 12:10, pages 929.
Crossref
Feng Li, Syeda Qasim, Dapeng Li & Q. Ping Dou. (2022) Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator. Seminars in Cancer Biology 83, pages 335-352.
Crossref
Z. G. Tadtaeva, A. N. Galustyan, М. Yu. Krivdina, V. V. Rusanovsky, E. A. Efet, A. Е. Krivoshein, N. A. Kuritsyna & О. A. Gromova. (2022) Myoclonic epilepsy with ragged red fibers in childhood. Epilepsy and paroxysmal conditions 14:1, pages 28-36.
Crossref
Ji-Hoon Na, Min Jung Lee, Chul Ho Lee & Young-Mock Lee. (2021) Association Between Epilepsy and Leigh Syndrome With MT-ND3 Mutation, Particularly the m.10191T>C Point Mutation. Frontiers in Neurology 12.
Crossref
Philipp Burow, Marc Haselier, Steffen Naegel, Leila Motlagh Scholle, Charly Gaul & Torsten Kraya. (2021) The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine. Cells 10:9, pages 2471.
Crossref
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago-Ferrante, Ana Felix, Sharon A. O’Toole, John J. O’Leary, Mark P. Ward, James Beirne, Angel Yordanov, Mariela Vasileva-Slaveva, Yashwanth Subbannayya, Francesca Pentimalli, Antonio Giordano & Jean Calleja-Agius. (2021) LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?. International Journal of Molecular Sciences 22:15, pages 7829.
Crossref
Anna Giménez-Palomo, Seetal Dodd, Gerard Anmella, Andre F. Carvalho, Giselli Scaini, Joao Quevedo, Isabella Pacchiarotti, Eduard Vieta & Michael Berk. (2021) The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment. Frontiers in Psychiatry 12.
Crossref
Shuang Wang, Jing Miao & Jiachun Feng. (2021) Case Report: Mitochondrial Encephalomyopathy Presents as Epilepsy, Ataxia, and Dystonia With a Rare Mutation in MT-TW. Frontiers in Neurology 12.
Crossref
Marcus P.J. van Diemen, Ellen P. Hart, Anthony Abbruscato, Liz Mead, Ilse van Beelen, Sandrin C. Bergheanu, Pieter W. Hameeteman, Emma Coppen, Jessica Y. Winder, Matthijs Moerland, Hermien Kan, Jeroen van der Grond, Andrew Webb, Raymund A.C. Roos & Geert Jan Groeneveld. (2020) Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study. British Journal of Clinical Pharmacology 87:5, pages 2290-2302.
Crossref
Douglas Yeung Leong, Rei Yen Chee & Yit Shiang Lui. (2021) Psychiatric care for a person with MELAS syndrome: A case report. Clinical Case Reports 9:5.
Crossref
Patricia Piña-Sánchez, Antonieta Chávez-González, Martha Ruiz-Tachiquín, Eduardo Vadillo, Alberto Monroy-García, Juan José Montesinos, Rocío Grajales, Marcos Gutiérrez de la Barrera & Hector Mayani. (2021) Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical Perspective. Cancer Control 28, pages 107327482110387.
Crossref
Castanares-Zapatero Diego & Hantson Philippe. 2021. Mitochondrial Dysfunction and Nanotherapeutics. Mitochondrial Dysfunction and Nanotherapeutics 203 220 .
Manuela Schubert Baldo & Laura Vilarinho. (2020) Molecular basis of Leigh syndrome: a current look. Orphanet Journal of Rare Diseases 15:1.
Crossref
Yuanjun Lu, Yau-Tuen Chan, Hor-Yue Tan, Sha Li, Ning Wang & Yibin Feng. (2020) Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy. Molecular Cancer 19:1.
Crossref
Josef Finsterer. (2020) Clinical Therapeutic Management of Human Mitochondrial Disorders. Pediatric Neurology 113, pages 66-74.
Crossref
Tirso González-Pinto González, Javier Almeida Velasco, Ana Moreno Estébanez, Garazi Agirre Beitia, Laura Cabral Martínez, Irene Díaz Cuervo & Amaia Martínez Arroyo. (2020) Acute management of a stroke-like episode in MELAS syndrome: What should we know?. eNeurologicalSci 20, pages 100249.
Crossref
Josef Finsterer, Fulvio A. Scorza, Ana C Fiorini & Carla A. Scorza. (2020) Mitochondrial myoclonic epilepsy requires specific treatment. Seizure 78, pages 168-169.
Crossref
Tereza Cikánková, Zdeněk Fišar & Jana Hroudová. (2019) In vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism. Naunyn-Schmiedeberg's Archives of Pharmacology 393:5, pages 797-811.
Crossref
M. ĽUPTÁK & J. HROUDOVÁ. (2019) Important Role of Mitochondria and the Effect of Mood Stabilizers on Mitochondrial Function. Physiological Research, pages S3-S15.
Crossref
Reza Heidari. (2019) The footprints of mitochondrial impairment and cellular energy crisis in the pathogenesis of xenobiotics-induced nephrotoxicity, serum electrolytes imbalance, and Fanconi’s syndrome: A comprehensive review. Toxicology 423, pages 1-31.
Crossref
Yu Hongo, Juntaro Kaneko, Hiroki Suga, Daisuke Ishima, Eiji Kitamura, Tsugio Akutsu, Yuya Onozawa, Naomi Kanazawa, Tomohide Goto, Kazutoshi Nishiyama & Takahiro Iizuka. (2019) A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features. Journal of Neurology 266:6, pages 1459-1472.
Crossref
Josef Finsterer. (2019) Mitochondrial metabolic stroke: Phenotype and genetics of stroke-like episodes. Journal of the Neurological Sciences 400, pages 135-141.
Crossref
Josef Finsterer. (2019) Management of NARS2-Related Mitochondrial Disorder is Complex. Pediatric Neurology 93, pages 64.
Crossref
Josef Finsterer. (2019) Beneficiality of combined levetiracetam, clonazepam for myoclonus in MERRF requires further confirmation. Chinese Medical Journal 132:5, pages 622-623.
Crossref
Sho Akai, Shingo Oda & Tsuyoshi Yokoi. (2018) Strain and interindividual differences in lamotrigine‐induced liver injury in mice. Journal of Applied Toxicology 39:3, pages 451-460.
Crossref
Zhe Zhang, Dan-Hua Zhao, Xu-Tong Zhao, Xiao Zhang, Hui Xiong, Xin-Hua Bao, Yun Yuan & Zhao-Xia Wang. (2019) Levetiracetam administration is correlated with lower mortality in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Chinese Medical Journal 132:3, pages 269-274.
Crossref
Josef Finsterer & Anabela Oliveira Bandeira. (2019) ADVERSE REACTION TO ANESTHESIA IN A M.8993T>C CARRIER WITH LEIGH SYNDROME. Revista Paulista de Pediatria 37:1, pages 135-136.
Crossref
Margarida Paiva Coelho, Esmeralda Martins & Laura Vilarinho. (2018) Diagnosis, management, and follow-up of mitochondrial disorders in childhood: a personalized medicine in the new era of genome sequence. European Journal of Pediatrics 178:1, pages 21-32.
Crossref
Elise Vantroys, Joél Smet, Arnaud V. Vanlander, Sarah Vergult, Ruth De Bruyne, Frank Roels, Hedwig Stepman, Herbert Roeyers, Björn Menten & Rudy Van Coster. (2018) Severe hepatopathy and neurological deterioration after start of valproate treatment in a 6-year-old child with mitochondrial tryptophanyl-tRNA synthetase deficiency. Orphanet Journal of Rare Diseases 13:1.
Crossref
Josef Finsterer. (2018) Stroke-like episodes in coenzyme-Q deficiency may respond to NO-precursors and non-mitochondrion-toxic antiepileptic drugs. Molecular Genetics and Metabolism Reports 17, pages 56.
Crossref
Josef Finsterer. (2018) Stroke-like episodes in coenzyme-Q deficiency may respond to NO-precursors and non-mitochondrion-toxic antiepileptic drugs. Molecular Genetics and Metabolism Reports 17, pages 42.
Crossref
Josef Finsterer, Fulvio A Scorza & Carla A Scorza. (2018) Antiepileptic treatment may determine the outcome of FARS2 mutation carriers. Molecular Genetics and Metabolism Reports 17, pages 45.
Crossref
Li-Jun Su, Yu-Liang Wang, Tao Han, Shan Qiao, Ke-Jun Zang, Huai-Kuan Wu, Yong-Xin Su, Ling-Ling Liu & Xue-Wu Liu. (2018) Antimyoclonic Effect of Levetiracetam and Clonazepam Combined Treatment on Myoclonic Epilepsy with Ragged-Red Fiber Syndrome with m.8344A>G Mutation. Chinese Medical Journal 131:20, pages 2433-2438.
Crossref
K. Tilmant, H. Gerets, P. De Ron, E. Hanon, C. Bento-Pereira & F.A. Atienzar. (2018) In vitro screening of cell bioenergetics to assess mitochondrial dysfunction in drug development. Toxicology in Vitro 52, pages 374-383.
Crossref
Josef Finsterer & Sinda Zarrouk-Mahjoub. (2018) Phenotypic variability of MTO1-deficiency. Molecular Genetics and Metabolism Reports 15, pages 28-29.
Crossref
RODRIGO M. DA COSTA, KARINA KARMIRIAN & STEVENS K. REHEN. (2018) Deformation of Mitochondrial Cristae in Human Neural Progenitor Cells Exposed to Valproic Acid. Anais da Academia Brasileira de Ciências 90:2 suppl 1, pages 2223-2232.
Crossref
Reza Heidari, Faezeh Jafari, Forouzan Khodaei, Babak Shirazi Yeganeh & Hossein Niknahad. (2018) Mechanism of valproic acid-induced Fanconi syndrome involves mitochondrial dysfunction and oxidative stress in rat kidney. Nephrology 23:4, pages 351-361.
Crossref
Mohammed Almannai & Ayman W. El-Hattab. (2018) Inborn Errors of Metabolism with Seizures. Pediatric Clinics of North America 65:2, pages 279-299.
Crossref
Viruna Neergheen, Alex Dyson, Luke Wainwright & Iain P. Hargreaves. 2018. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants 457 473 .
Josef Finsterer & Fulvio A. Scorza. (2017) Effects of antiepileptic drugs on mitochondrial functions, morphology, kinetics, biogenesis, and survival. Epilepsy Research 136, pages 5-11.
Crossref
Alan W.C. Yuen, Isabel A. Walcutt & Josemir W. Sander. (2017) An acidosis-sparing ketogenic (ASK) diet to improve efficacy and reduce adverse effects in the treatment of refractory epilepsy. Epilepsy & Behavior 74, pages 15-21.
Crossref
Josef Finsterer & Sinda Zarrouk-Mahjoub. (2017) Management of epilepsy in MERRF syndrome. Seizure 50, pages 166-170.
Crossref
Eleni Paleologou, Naila Ismayilova & Maria Kinali. (2017) Use of the Ketogenic Diet to Treat Intractable Epilepsy in Mitochondrial Disorders. Journal of Clinical Medicine 6:6, pages 56.
Crossref
Yüksel Totan, Emre Güler, Aslıhan Yüce & MehmetSerdar Dervişogulları. (2017) The adverse effects of valproic acid on visual functions in the treatment of retinitis pigmentosa. Indian Journal of Ophthalmology 65:10, pages 984.
Crossref
Qing-Qing Tao, Hong-Fu Li & Sheng Chen. 2017. Inherited Neurological Disorders. Inherited Neurological Disorders 35 49 .
Madhusudanarao Vuda & Ashwin Kamath. (2016) Drug induced mitochondrial dysfunction: Mechanisms and adverse clinical consequences. Mitochondrion 31, pages 63-74.
Crossref
Josef Finsterer & Sinda Zarrouk-Mahjoub. (2016) Mitochondrial neuropathy affects peripheral and cranial nerves and is primary or secondary or both. Neuromuscular Disorders 26:8, pages 548-549.
Crossref
Josef Finsterer & Sinda Zarrouk-Mahjoub. (2016) Prevalence and Outcome of Mitochondrial Epilepsy. Annals of Neurology 80:2, pages 313-314.
Crossref
J. Finsterer & S. Zarrouk-Mahjoub. (2016) Mitochondriale Erkrankungen benötigen ein umfassendes perioperatives ManagementMitochondrial disorders require a comprehensive perioperative management. Der Anaesthesist 65:6, pages 469-470.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 303 337 .
Harold A. Coleman & Helena C. Parkington. 2016. Prenatal and Postnatal Determinants of Development. Prenatal and Postnatal Determinants of Development 203 219 .
Josef Finsterer. 2017. Pharmacology of Mitochondria. Pharmacology of Mitochondria 473 488 .
Rodrigo Furtado Madeiro da CostaMichelle Louise KormannAntonio GalinaStevens Kastrup Rehen. (2015) Valproate Disturbs Morphology and Mitochondrial Membrane Potential in Human Neural Cells. Applied In Vitro Toxicology 1:4, pages 254-261.
Crossref
Davide Germano, Marianne Uteng, Francois Pognan, Salah-Dine Chibout & Armin Wolf. (2015) Determination of liver specific toxicities in rat hepatocytes by high content imaging during 2-week multiple treatment. Toxicology in Vitro 30:1, pages 79-94.
Crossref
Paulo José Lorenzoni, Lineu Cesar Werneck, Cláudia Suemi Kamoi Kay, Carlos Eduardo Soares Silvado & Rosana Herminia Scola. (2015) When should MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) be the diagnosis?. Arquivos de Neuro-Psiquiatria 73:11, pages 959-967.
Crossref
Eylert Brodtkorb. 2015. The Treatment of Epilepsy. The Treatment of Epilepsy 193 204 .
Josef Finsterer & Sinda Zarrouk-Mahjoub. (2015) Focal and Generalized Seizures May Occur in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes (MELAS) Patients. Journal of Child Neurology 30:11, pages 1553-1554.
Crossref
Ayman W. El-Hattab, Adekunle M. Adesina, Jeremy Jones & Fernando Scaglia. (2015) MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Molecular Genetics and Metabolism 116:1-2, pages 4-12.
Crossref
Tomomi Imamura, Shingo Konno, Masashi Inoue, Mayumi Murata, Hiroshi Nakazora, Hideki Sugimoto & Toshiki Fujioka. (2015) Convulsion and cerebellar ataxia associated with maternally inherited diabetes and deafness: a case report. Clinical Case Reports 3:7, pages 656-659.
Crossref
Shengbiao Li, Jingyi Guo, Zhongfu Ying, Shen Chen, Liang Yang, Keshi Chen, Qi Long, Dajiang Qin, Duanqing Pei & Xingguo Liu. (2015) Valproic acid‐induced hepatotoxicity in alpers syndrome is associated with mitochondrial permeability transition pore opening‐dependent apoptotic sensitivity in an induced pluripotent stem cell model. Hepatology 61:5, pages 1730-1739.
Crossref
Josef Finsterer & Parayil Sankaran Bindu. (2015) Therapeutic Strategies for Mitochondrial Disorders. Pediatric Neurology 52:3, pages 302-313.
Crossref
Ronald J. Sokol. 2014. Liver Disease in Children. Liver Disease in Children 603 630 .
Steve S. Chung & Courtney Schusse. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 133 169 .
Simon Horslen. 2014. Diseases of the Liver in Children. Diseases of the Liver in Children 107 131 .
Andreas Hermann. 2014. Chorea. Chorea 31 55 .
Katrin Hayess, Christian Riebeling, Ralph Pirow, Matthias Steinfath, Dana Sittner, Birgitta Slawik, Andreas Luch & Andrea E.M. Seiler. (2013) The DNT-EST: A predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro. Toxicology 314:1, pages 135-147.
Crossref
Manuela G. Neuman, Radu M. Nanau, Tawfeeq Shekh-Ahmad, Boris Yagen & Meir Bialer. (2013) Valproic acid derivatives signal for apoptosis and repair in vitro. Clinical Biochemistry 46:15, pages 1532-1537.
Crossref
Radu M. Nanau & Manuela G. Neuman. (2013) Adverse drug reactions induced by valproic acid. Clinical Biochemistry 46:15, pages 1323-1338.
Crossref
J. Finsterer & S. Zarrouk Mahjoub. (2013) Mitochondrial epilepsy in pediatric and adult patients. Acta Neurologica Scandinavica 128:3, pages 141-152.
Crossref
Divya S. Khurana, Ignacio Valencia, Michael J. Goldenthal & Agustín Legido. (2013) Mitochondrial Dysfunction in Epilepsy. Seminars in Pediatric Neurology 20:3, pages 176-187.
Crossref
Josef Finsterer & Sinda Zarrouk Mahjoub. (2013) Presentation of adult mitochondrial epilepsy. Seizure 22:2, pages 119-123.
Crossref
Iris E. Martínez-Juárez, Laura Elena Hernández-Vanegas, Nayelli Rodríguez y Rodríguez, Jorge Alfredo León-Aldana & Antonio V. Delgado-Escueta. 2013. Pharmacoresistance in Epilepsy. Pharmacoresistance in Epilepsy 11 25 .
Hu Chen, Svetlana Dzitoyeva & Hari Manev. (2012) Effect of valproic acid on mitochondrial epigenetics. European Journal of Pharmacology 690:1-3, pages 51-59.
Crossref
Josef Finsterer & Sinda Zarrouk Mahjoub. (2012) Epilepsy in mitochondrial disorders. Seizure 21:5, pages 316-321.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.